...
首页> 外文期刊>Molecular syndromology >FTO and INSIG2 genotyping combined with metabolic and anthropometric phenotyping of morbidly obese patients
【24h】

FTO and INSIG2 genotyping combined with metabolic and anthropometric phenotyping of morbidly obese patients

机译:病态肥胖患者的FTO和INSIG2基因分型与代谢和人体计量学表型结合

获取原文
获取原文并翻译 | 示例

摘要

Obesity is a major health problem worldwide. Associations of obesity with common variants of the fat mass- and obesity-associated gene (FTO) and insulin-induced gene 2 (INSIG2) have been reported in various studies. We aimed to further investigate the association of 2 single nucleotide polymorphisms (SNPs), rs9939609 in FTO and rs7566605 in INSIG2, with body mass index (BMI) and other anthropometric and metabolic parameters in subjects with morbid obesity (BMI ≥40). SNPs rs9939609 and rs7566605 were genotyped in 124 unrelated morbidly obese patients (mean BMI = 50, range 40.1-77.1) from Mainz, Germany, and in 253 normal controls without a history of morbid obesity. Metabolic and anthropometric parameters were analyzed in 109 of the 124 patients, and associations with the genotype data were examined. The high-risk AA genotype for FTO rs9939609 was observed in 32.3% of patients versus 15.8% of controls (p = 0.0004) and was associated with an increased obesity risk [odds ratio (OR) = 2.54, 95% confidence interval (CI) = 1.53-4.21]. The intermediate-risk AT genotype was found in patients and controls at similar frequencies (48.4 vs. 48.6%, OR = 0.99). The low-risk TT genotype for rs9939609 was found in 19.4% of patients (35.5% of controls; p = 0.0013) and was associated with a decreased risk for morbid obesity (OR = 0.43, CI = 0.26-0.73). In contrast, INSIG2 rs7566605 showed no association with obesity in our patients. Evaluation of metabolic data indicated associations between the high-risk FTO genotype (rs9939609-AA) and increased levels of serum glutamic oxaloacetic transaminase (GOT) and between the high-risk INSIG2 genotype (rs7566605-CC) and lower waist-to-hip ratio and lower hemoglobin A1c (HbA1c) levels. Our results confirm an association of the FTO SNP with extreme obesity. However, we found no association of the potential obesity risk allele of INSIG2 in our sample and thus cannot confirm an association of the INSIG2 CC genotype with obesity. We identified an association between the high-risk FTO genotype (rs9939609-AA) and higher GOT levels, which could possibly reflect the increased frequency of nonalcoholic steatohepatitis with obesity. We also detected associations of the high-risk INSIG2 genotype (rs7566605-CC) with lower waist-to-hip ratios and lower HbA1c levels, which may indicate amelioration of impaired glucose tolerance and type 2 diabetes for patients with this genotype after bariatric surgery.
机译:肥胖是世界范围内的主要健康问题。肥胖与肥胖和肥胖相关基因(FTO)和胰岛素诱导基因2(INSIG2)的常见变异之间存在关联。我们旨在进一步研究2个单核苷酸多态性(SNP),FTO中的rs9939609和INSIG2中的rs7566605与病态肥胖(BMI≥40)受试者的体重指数(BMI)以及其他人体测量和代谢参数之间的关系。 SNP rs9939609和rs7566605在来自德国美因兹的124位无关的病态肥胖患者(平均BMI = 50,范围40.1-77.1)和253位无病态肥胖病史的正常对照中进行了基因分型。在124名患者中的109名患者中分析了代谢和人体测量参数,并检查了与基因型数据的相关性。在32.3%的患者中观察到FTO rs9939609的高风险AA基因型,而在对照组中则是15.8%(p = 0.0004),这与肥胖风险增加相关[赔率(OR)= 2.54,95%置信区间(CI) = 1.53-4.21]。在患者和对照中发现中等风险AT基因型的频率相似(48.4 vs. 48.6%,OR = 0.99)。在19.4%的患者中发现了rs9939609的低风险TT基因型(对照组为35.5%; p = 0.0013),并且与病态肥胖的风险降低相关(OR = 0.43,CI = 0.26-0.73)。相反,在我们的患者中INSIG2 rs7566605与肥胖无关。代谢数据评估表明,高风险的FTO基因型(rs9939609-AA)与血清谷氨酸草酰乙酸转氨酶(GOT)水平升高之间以及高风险的INSIG2基因型(rs7566605-CC)与较低的腰臀比之间存在关联和较低的血红蛋白A1c(HbA1c)水平。我们的结果证实FTO SNP与极端肥胖有关。但是,我们在样本中未发现INSIG2的潜在肥胖风险等位基因的关联,因此无法确认INSIG2 CC基因型与肥胖的关联。我们发现高危FTO基因型(rs9939609-AA)与较高的GOT水平之间存在关联,这可能反映出肥胖引起的非酒精性脂肪性肝炎的发生频率增加。我们还检测到高风险的INSIG2基因型(rs7566605-CC)与较低的腰臀比和较低的HbA1c水平相关联,这可能表明减肥后该基因型患者的糖耐量降低和2型糖尿病得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号